PMU-Autor/inn/en
Grimm JochenAbstract
Components of carotid atherosclerotic plaques can reliably be identified and quantified using high resolution in vivo 3-Tesla CMR. It is suspected that lipid apheresis therapy in addition to lowering serum lipid levels also has an influence on development and progression of atherosclerotic plaques. The purpose of this study was to evaluate the influence of chronic lipid apheresis (LA) on the composition of atherosclerotic carotid plaques.
Useful keywords (using NLM MeSH Indexing)
Aged
Aged, 80 and over
Blood Component Removal/methods*
Carotid Arteries/pathology*
Carotid Artery Diseases/diagnosis*
Carotid Artery Diseases/etiology
Carotid Artery Diseases/pathology
Carotid Stenosis/diagnosis
Carotid Stenosis/pathology
Case-Control Studies
Contrast Media
Cross-Sectional Studies
Disease Progression
Dyslipidemias/blood
Dyslipidemias/complications
Dyslipidemias/therapy*
Female
Humans
Lipids/blood*
Magnetic Resonance Imaging*
Male
Middle Aged
Organometallic Compounds
Plaque, Atherosclerotic*
Predictive Value of Tests
Prospective Studies
Risk Factors
Time Factors
Find related publications in this database (Keywords)
Atherosclerosis